Tech Times on MSN
Nasal mRNA drug cuts common cold virus load 40-fold in asthma patients, validating COVID-vaccine technology as a respiratory antiviral
Intranasal mRNA therapy for asthma reduced rhinovirus viral load 40-fold versus placebo in a Phase 2a trial, Ethris announced November 5. The drug, ETH47, also cut lower respiratory symptoms 58% and ...
ABP News on MSN
Delhi AQI crosses 400: 5 health complications caused by prolonged exposure to toxic air
Delhi's air quality deteriorated sharply after Diwali, with the Air Quality Index (AQI) crossing 400 on November 9. The air ...
Newsis [Financial News] You can have pneumonia even without a cough or fever. In older adults, loss of appetite, sudden ...
UR Medicine explains common causes of nasal congestion and ways to ease symptoms at home. A persistent cough, fever or ...
As Delhi-NCR battles winter air pollution, doctors explain how PM2.5, PM10 and toxic gases irritate the airways, trigger ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results